Literature DB >> 8310514

Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients. A comparison of seven virologic methods.

R C Hackman1, J L Wolford, C A Gleaves, D Myerson, M D Beauchamp, J D Meyers, G B McDonald.   

Abstract

This is a retrospective study of 54 consecutive upper gastrointestinal endoscopies in marrow graft recipients performed to determine the incidence and distribution of CMV infection in symptomatic patients and to compare the sensitivities of 7 CMV detection techniques. At each endoscopy, 3 biopsies were obtained from the esophagus, stomach, and duodenum. Each of the 3 biopsies was assayed for CMV by different techniques. Enteric CMV was identified by one or more techniques in 52 of 486 (11%) biopsies from 14 infected patients. All patients infected with CMV initially had nausea and vomiting. In 13 of these patients, there was esophageal CMV, often associated with stomach (10 patients) and duodenal (7 patients) involvement. CMV infection of the esophagus was never identified cytologically in esophageal imprints or histologically, immunohistologically, or by DNA hybridization in esophageal epithelial cells. The most sensitive diagnostic methods were conventional and centrifugation cultures, which each identified CMV in 17 of the 30 (57%) organs positive by any technique. Indirect fluorescent antibody (IFA) staining for a late CMV antigen detected 53%, followed by in situ DNA hybridization (40%), IFA and immunoperoxidase (IP) staining for an early CMV antigen (37% and 43%), and routine histology (30%). Although no single detection technique is completely adequate for the rapid identification of CMV in small endoscopic biopsies, centrifugation culture is the method of choice, with supplementary immunohistology and in situ hybridization of archival tissue if needed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8310514     DOI: 10.1097/00007890-199401001-00014

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  How we treat cytomegalovirus in hematopoietic cell transplant recipients.

Authors:  Michael Boeckh; Per Ljungman
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

2.  How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver.

Authors:  George B McDonald
Journal:  Blood       Date:  2016-01-04       Impact factor: 22.113

3.  Successful treatment with ganciclovir for cytomegalovirus duodenitis following allogenic bone marrow transplantation.

Authors:  J H Ahn; J H Lee; K H Lee; W K Kim; J S Lee; H Bahng; H Y Jung; Y S Kim; O Kim; S H Kim
Journal:  Korean J Intern Med       Date:  1999-01       Impact factor: 2.884

Review 4.  Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; J Bierwirth; D Buchheidt; O A Cornely; M Hentrich; G Maschmeyer; E Schalk; J J Vehreschild; Maria J G T Vehreschild
Journal:  Ann Hematol       Date:  2017-11-24       Impact factor: 3.673

5.  Endoscopic evaluation in gastrointestinal graft-versus-host disease: comparisons with histological findings.

Authors:  Dae Young Cheung; Jin Il Kim; Soon Sub Kim; Hye Young Sung; Se-Hyun Cho; Soo-Heon Park; Joon-Yeol Han; Jae Kwang Kim; Jong-Wook Lee; Woo-Sung Min; Gyeong-Sin Park; Chang Suk Kang
Journal:  Dig Dis Sci       Date:  2008-04-10       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.